Is PRVB or FCPT a better dividend investment in 2026?

PRVB currently yields 8.01% with a 5% 5-year dividend growth rate. FCPT yields 6.05% with 5% growth. The better choice depends on your goal: PRVB offers higher current income.

What is the dividend yield difference between PRVB and FCPT?

PRVB has a forward dividend yield of 8.01% ($2.00/share annually). FCPT yields 6.05% ($1.43/share annually). The yield gap is 1.96 percentage points.

Home › Compare › PRVB vs FCPT

PRVB vs FCPT: Dividend Comparison 2026

PRVB yields 8.01% · FCPT yields 6.05%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 FCPT wins by $15.1K in total portfolio value· pulled ahead in Year 3

INVESTMENT

TIME HORIZON10 years

PRVB

● Live price

8.01%

Share price

$24.98

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$34.0K

Annual income

$1,328.87

Full PRVB calculator →

FCPT

● Live price

6.05%

Share price

$23.65

Annual div

$1.43

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$49.1K

Annual income

$5,775.28

Full FCPT calculator →

Portfolio growth — PRVB vs FCPT

📍 FCPT pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PRVB	FCPT
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PRVB + FCPT cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PRVB pays

FCPT pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PRVB

Annual income on $10K today (after 15% tax)

$680.54/yr

After 10yr DRIP, annual income (after tax)

$1,129.54/yr

FCPT

Annual income on $10K today (after 15% tax)

$514.49/yr

After 10yr DRIP, annual income (after tax)

$4,908.99/yr

At 15% tax rate, FCPT beats the other by $3,779.45/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PRVB + FCPT for your $10,000?

PRVB: 50%FCPT: 50%

100% FCPT50/50100% PRVB

Portfolio after 10yr

$41.5K

Annual income

$3,552.07/yr

Blended yield

8.55%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

PRVB

Analyst Ratings

Buy

Consensus: Buy

Altman Z

8.7

Piotroski

2/9

FCPT

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$27.00

+14.2% upside vs current

Range: $25.00 — $29.00

Altman Z

1.4

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PRVB buys

FCPT buys

No recent congressional trades found for PRVB or FCPT in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPRVBFCPT

Forward yield	8.01% ✓	6.05%
Annual dividend / share	$2.00 ✓	$1.43
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$34.0K	$49.1K ✓
Annual income after 10y	$1,328.87	$5,775.28 ✓
Total dividends collected	$10.7K	$24.1K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold

Year-by-year: PRVB vs FCPT ($10,000, DRIP)

Year	PRVB Portfolio	PRVB Income/yr	FCPT Portfolio	FCPT Income/yr	Gap
1	$11,501	$800.64	$11,401	$700.92	+$100.00 → PRVB
2	$13,166	$860.55	$13,064	$864.84	+$102.00 → PRVB
3← crossover	$15,009	$920.73	$15,051	$1,072.48	$42.00 → FCPT
4	$17,040	$980.90	$17,442	$1,337.22	$402.00 → FCPT
5	$19,274	$1,040.82	$20,340	$1,677.08	$1.1K → FCPT
6	$21,723	$1,100.23	$23,880	$2,116.57	$2.2K → FCPT
7	$24,403	$1,158.93	$28,241	$2,689.36	$3.8K → FCPT
8	$27,328	$1,216.71	$33,660	$3,442.07	$6.3K → FCPT
9	$30,514	$1,273.41	$40,456	$4,439.95	$9.9K → FCPT
10	$33,979	$1,328.87	$49,063	$5,775.28	$15.1K → FCPT

PRVB vs FCPT: Complete Analysis 2026

PRVB — Stock

Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China. Provention Bio, Inc. was incorporated in 2016 and is headquartered in Red Bank, New Jersey.

Full PRVB Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →

📬

Get this PRVB vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PRVB vs SCHD PRVB vs JEPI PRVB vs O PRVB vs KO PRVB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.